Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
University Hospital, Strasbourg, France |
---|---|
Information provided by: | University Hospital, Strasbourg, France |
ClinicalTrials.gov Identifier: | NCT00696033 |
Aims :
Hypothesis :
Condition | Intervention |
---|---|
Healthy Subjects |
Drug: Diazepam Drug: Lorazepam Drug: placebo |
Study Type: | Interventional |
Study Design: | Randomized, Double Blind (Subject, Investigator), Placebo Control, Crossover Assignment |
Official Title: | Exploring the Effects of Diazepam and Lorazepam on the Neural Correlates of Perceptual Priming and Explicit Memory in Healthy Volunteers |
Enrollment: | 22 |
Study Start Date: | July 2007 |
Study Completion Date: | December 2008 |
Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental
Oral Lorazepam
|
Drug: Lorazepam
Lorazépam drug (0,038 mg/kg) on a single oral intake
|
2: Experimental
Oral Diazepam
|
Drug: Diazepam
Diazépam drug (0,3 mg/kg) on a single oral intake
|
3: Placebo Comparator
Oral placebo
|
Drug: placebo
lorazépam placebo or Diazépam placebo
|
Ages Eligible for Study: | 18 Years to 30 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion criteria:
France | |
Clinique psychiatrique, hôpital civil | |
Strasbourg, France, 67091 | |
Centre d'investigation clinique, hôpital civil | |
Strasbourg, France, 67091 |
Principal Investigator: | Pierre Vidailhet, MD | Hôpitaux universitaires de strasbourg |
Responsible Party: | University Hospital, Strasbourg, France ( Emmanuel LAVOUE, directeur Adjoint ) |
Study ID Numbers: | 3777 |
Study First Received: | June 9, 2008 |
Last Updated: | December 29, 2008 |
ClinicalTrials.gov Identifier: | NCT00696033 |
Health Authority: | France: Ministry of Health |
Benzodiazepines Lorazepam Diazepam Memory |
Perceptual priming Functional brain imaging FMRI |
Lorazepam Diazepam Healthy |
Anesthetics, Intravenous Neurotransmitter Agents Tranquilizing Agents Molecular Mechanisms of Pharmacological Action GABA Modulators Physiological Effects of Drugs Psychotropic Drugs Gastrointestinal Agents Anesthetics Antiemetics Central Nervous System Depressants Neuromuscular Agents |
Pharmacologic Actions Adjuvants, Anesthesia Anesthetics, General Autonomic Agents Therapeutic Uses Muscle Relaxants, Central Hypnotics and Sedatives GABA Agents Anti-Anxiety Agents Peripheral Nervous System Agents Central Nervous System Agents Anticonvulsants |